Menu

Investors

2025 Third quarter announcement

We announced our third quarter 2025 results on Wednesday 29 October.

Q3 2025 resultsAnnual Report 2024
Emma Walmsley
Close video

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Why invest in GSK?

Speeches and presentations

Deborah Waterhouse

Evercore 8th Annual Evercore Healthcare Conference, Miami

03 September 2025

Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, participated at the Evercore 8th Annual Evercore Healthcare Conference in Miami on Wednesday, 3 December 2025.

Tony Wood

Jefferies London Healthcare Conference, London

18 November 2025

Tony Wood, Chief Scientific Officer, attended the Jefferies Healthcare Conference in London on Tuesday, 18 and Wednesday, 19 November 2025.

Julie Brown

J.P. Morgan UK Leaders Conference, London

18 November 2025

Julie Brown, Chief Financial Officer, attended the J.P. Morgan UK Leaders Conference in London on Tuesday, 18 November 2025.

David Redfern

UBS European Conference, London

12 November 2025

David Redfern, President Corporate Development, attended the UBS European Conference in London on Wednesday, 12 November 2025.

Julie Brown sat on a grey sofa smiling

BofA 2025 Global Healthcare Conference, London

24 September 2025

Julie Brown, Chief Financial Officer and Tony Wood, Chief Scientific Officer, participated in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 24 September 2025.

Shareholder information

Shareholder information

GSK dividend

GSK laboratory photo

Dividend calculators (GBp/USD)

Calculate an estimate of your dividend payment

GSK lab equipment photo

Dividend calendar

Details of our dividend timetable by quarter

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool

Behind the science

Read our latest articles

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

‘How do we improve trust in prevention? The answer lies closer to home than you might think’

‘We’re aiming to protect even more children’: Research starts on second-generation malaria vaccine to prevent most severe form of disease

Behind the science magazine
two scientists talking

Get in touch with our investor team

Investor contact details

You might also like

Pipeline

Our pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative medicines and vaccines

Our leading scientists

Meet the world-leading scientists who are uniting science, technology and talent to get ahead of disease together.

Governance

At GSK we are committed to operating at the highest standards of corporate governance

Continue to Media